Bone glue with robust adhesion is
crucial for treating
complicated
bone fractures, but it remains a formidable challenge to develop a
“true” bone glue with high adhesion strength, degradability,
bioactivity, and satisfactory operation time in clinical scenarios.
Herein, inspired by the hydroxyapatite and collagen matrix composition
of natural bone, we constructed a nanohydroxyapatite (nHAP) reinforced
osteogenic backbone-degradable superglue (O-BDSG) by in situ radical ring-opening polymerization. nHAP significantly enhances
adhesive cohesion by synergistically acting as noncovalent connectors
between polymer chains and increasing the molecular weight of the
polymer matrix. Moreover, nHAP endows the glue with bioactivity to
promote osteogenesis. The as-prepared glue presented a 9.79 MPa flexural
adhesion strength for bone, 4.7 times that without nHAP, and significantly
surpassed commercial cyanoacrylate (0.64 MPa). O-BDSG exhibited degradability
with 51% mass loss after 6 months of implantation. In vivo critical defect and tibia fracture models demonstrated the promoted
osteogenesis of the O-BDSG, with a regenerated bone volume of 75%
and mechanical function restoration to 94% of the native tibia after
8 weeks. The glue can be flexibly adapted to clinical scenarios with
a curing time window of about 3 min. This work shows promising prospects
for clinical application in orthopedic surgery and may inspire the
design and development of bone adhesives